TheraPulse ATP for preventing and treating pressure ulcers.
In the modern healthcare environment where evidence-based best practice is key in seeking quality improvements for patient care, using treatment and therapies that have evidence of clinical efficacy is paramount. The current evidence bases supporting pulsating air suspension therapy is excellent and the improved lymphatic flow and enhanced microcirculation along with reduction of pressure ulcer potential (El-Habbal and Smith, 1996; Gunther and Brofeldt, 1996) ensures a firm place for TheraPulse ATP (KCI Medical) in reduction of oedema and pressure ulcers in the critically ill patient.